-
Kenya: All Set For Beginning of Clinical Trial for Three Possible COVID-19 Drugs
Nation, 5 May 2020
Kenyan researchers have joined their international counterparts in the search for a cure for Covid-19, with plans for clinical trials for three drugs. Read more »
Kenya All Set for COVID-19 Clinical Trials
Researchers are seeking approval to conduct the trials to determine if Remdesivir, an antiretroviral drug approved by the U.S. Food and Drug Administration for emergency treatment of COVID-19, as well as the anti-malaria drug hydroxychloroquine, and Lopinavir/ritonavir can effectively treat COVID-19 patients in Kenya.
Dr Loice Achieng Ombajo at the Kenyatta National Hospital Infectious Disease Unit. She is the principal investigator in the study.
InFocus
-
Over 18 million students in Kenya have been affected by the closure of schools. An extended period of closure will impact children's wellbeing and have a long-term impact on ... Read more »
-
Treasury Cabinet Secretary Ukur Yatani has downgraded this year's economic growth outlook to between 1.8 and 2.5% from the previous forecast of 6%, saying that his department will ... Read more »
-
The ministry of health has denied knowledge of plans by Oxford University researchers to test their vaccines on Kenyans because of the lower COVID-19 transmission rates in the ... Read more »
